{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:56:13Z","timestamp":1786985773025,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Chemical Biology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.cbpa.2022.102127","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T05:32:59Z","timestamp":1646285579000},"page":"102127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Metallomics and other omics approaches in antiparasitic metal-based drug research"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5386-6225","authenticated-orcid":false,"given":"Gonzalo","family":"Scalese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kateryna","family":"Kostenkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7792-3450","authenticated-orcid":false,"given":"Debbie C.","family":"Crans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8678-7374","authenticated-orcid":false,"given":"Dinorah","family":"Gambino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbpa.2022.102127_bib1","doi-asserted-by":"crossref","first-page":"102925","DOI":"10.1016\/j.bioorg.2019.102925","article-title":"Cisplatin: the first metal based anticancer drug","volume":"88","author":"Ghosh","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.cbpa.2022.102127_bib2","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1021\/acs.chemrev.5b00597","article-title":"The next generation of platinum drugs: targeted Pt(II) agents, nanoparticle delivery, and Pt(IV) prodrugs","volume":"116","author":"Johnstone","year":"2016","journal-title":"Chem Rev"},{"key":"10.1016\/j.cbpa.2022.102127_bib3","doi-asserted-by":"crossref","first-page":"12888","DOI":"10.1039\/D0SC04082G","article-title":"Metallodrugs are unique: opportunities and challenges of discovery and development","volume":"11","author":"Anthony","year":"2020","journal-title":"Chem Sci"},{"key":"10.1016\/j.cbpa.2022.102127_bib4","first-page":"41","article-title":"Classification of metal-based drugs according to their mechanisms of action","volume":"6","author":"Boros","year":"2020","journal-title":"Inside Chem"},{"key":"10.1016\/j.cbpa.2022.102127_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9050504","article-title":"Strategies for the improvement of metal-based chemotherapeutic treatments","volume":"9","author":"Cirri","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.cbpa.2022.102127_bib6","first-page":"438","article-title":"Proteomics as a tool to disclose the cellular and molecular mechanisms of selected anticancer gold compounds","author":"Gamberi","year":"2021","journal-title":"Coord Chem Rev"},{"key":"10.1016\/j.cbpa.2022.102127_bib7","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1021\/acs.chemrev.8b00396","article-title":"Metal drugs and the anticancer immune response","volume":"119","author":"Englinger","year":"2019","journal-title":"Chem Rev"},{"key":"10.1016\/j.cbpa.2022.102127_bib8","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1039\/C7CS00332C","article-title":"Structure-activity relationships for ruthenium and osmium anticancer agents - towards clinical development","volume":"47","author":"Meier-Menches","year":"2018","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.cbpa.2022.102127_sref9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ccr.2014.12.002","article-title":"Vanadium compounds in medicine","volume":"301","author":"Pessoa","year":"2015","journal-title":"Coord Chem Rev"},{"key":"10.1016\/j.cbpa.2022.102127_bib10","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1021\/acs.jmedchem.7b01689","article-title":"Ru(II) Compounds: next-generation anticancer metallotherapeutics?","volume":"61","author":"Thota","year":"2018","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.cbpa.2022.102127_bib11","first-page":"251","article-title":"Health benefits of vanadium and its potential as an anticancer agent","author":"Crans","year":"2018","journal-title":"Met Ions Life Sci"},{"key":"10.1016\/j.cbpa.2022.102127_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ymthe.2017.10.014","article-title":"Multi-modal potentiation of oncolytic virotherapy by vanadium compounds","volume":"26","author":"Selman","year":"2018","journal-title":"Mol Ther"},{"key":"10.1016\/j.cbpa.2022.102127_bib13","doi-asserted-by":"crossref","first-page":"15834","DOI":"10.1002\/anie.202005458","article-title":"A\u00a0short-lived but highly cytotoxic vanadium(V) complex as a potential drug lead for brain cancer treatment by intratumoral injections","volume":"59","author":"Levina","year":"2020","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.cbpa.2022.102127_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/metabo9060108","article-title":"Translational metabolomics: current challenges and future opportunities","volume":"9","author":"Pinu","year":"2019","journal-title":"Metabolites"},{"key":"10.1016\/j.cbpa.2022.102127_bib15","doi-asserted-by":"crossref","first-page":"13673","DOI":"10.1021\/acs.inorgchem.9b01199","article-title":"Metalloproteomics for unveiling the mechanism of action of metallodrugs","volume":"58","author":"Wang","year":"2019","journal-title":"Inorg Chem"},{"key":"10.1016\/j.cbpa.2022.102127_sref16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cbpa.2020.02.006","article-title":"Metalloproteomics in conjunction with other omics for uncovering the mechanism of action of metallodrugs: mechanism-driven new therapy development","volume":"55","author":"Wang","year":"2020","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.cbpa.2022.102127_bib17","first-page":"1","article-title":"Metals from cell to environment: connecting metallomics with other omics","volume":"3","author":"Singh","year":"2018","journal-title":"Open J Polit Sci"},{"key":"10.1016\/j.cbpa.2022.102127_sref18","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/s12276-020-0422-0","article-title":"Single-cell transcriptomics in cancer: computational challenges and opportunities","volume":"52","author":"Fan","year":"2020","journal-title":"Exp Mol Med"},{"issue":"Suppl 1","key":"10.1016\/j.cbpa.2022.102127_bib19","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1002\/pmic.200500374","article-title":"Environmental proteomics and metallomics","volume":"6","author":"Lopez-Barea","year":"2006","journal-title":"Proteomics"},{"key":"10.1016\/j.cbpa.2022.102127_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jprot.2018.12.001","article-title":"Ecotoxicoproteomics: a decade of progress in our understanding of anthropogenic impact on the environment","volume":"198","author":"Gouveia","year":"2019","journal-title":"J\u00a0Proteonomics"},{"key":"10.1016\/j.cbpa.2022.102127_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030778","article-title":"The metallome of lung cancer and its potential use as biomarker","volume":"20","author":"Callej\u00f3n-Leblic","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cbpa.2022.102127_bib22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.trac.2017.09.025","article-title":"Trends on (elemental and molecular) mass spectrometry based strategies for speciation and metallomics","volume":"104","author":"Montes-Bay\u00f3n","year":"2018","journal-title":"Trends Anal Chem"},{"key":"10.1016\/j.cbpa.2022.102127_bib23","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.3390\/ijms20194781","article-title":"The need for multi-omics biomarker signatures in precision medicine","volume":"20","author":"Olivier","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cbpa.2022.102127_bib24","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1351\/pac200072081453","article-title":"Guidelines for terms related to chemical speciation and fractionation of elements. Definitions, structural aspects, and methodological approaches (IUPAC Recommendations 2000)","volume":"72","author":"Templeton","year":"2000","journal-title":"Pure Appl Chem"},{"key":"10.1016\/j.cbpa.2022.102127_sref25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.trac.2017.09.023","article-title":"Advanced metallomics methods in anticancer metallodrug mode of action studies","volume":"104","author":"Holtkamp","year":"2018","journal-title":"Trends Anal Chem"},{"key":"10.1016\/j.cbpa.2022.102127_sref26","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1021\/acs.inorgchem.0c00969","article-title":"ESI-MS study of the interaction of potential oxidovanadium(IV) drugs and amavadin with model proteins","volume":"59","author":"Ugone","year":"2020","journal-title":"Inorg Chem"},{"key":"10.1016\/j.cbpa.2022.102127_bib27","first-page":"1","article-title":"Alteration of trace elements in multinodular goiter, thyroid adenoma, and thyroid cancer","author":"Stojsavljevic","year":"2021","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.cbpa.2022.102127_sref28","article-title":"Highlighting the roles of metals and speciation in Chemical Biology","author":"Kostenkova","year":"2021","journal-title":"Curr Opin Chem Biol submitted"},{"key":"10.1016\/j.cbpa.2022.102127_bib29","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ccr.2017.01.002","article-title":"Speciation of metal drugs, supplements and toxins in media and bodily fluids controls in\u00a0vitro activities","volume":"352","author":"Levina","year":"2017","journal-title":"Coord Chem Rev"},{"key":"10.1016\/j.cbpa.2022.102127_bib30","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1002\/anie.202015962","article-title":"Interaction with ribosomal proteins accompanies stress induction of the anticancer metallodrug BOLD-100\/KP1339 in the endoplasmic reticulum","volume":"60","author":"Neuditschko","year":"2021","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.cbpa.2022.102127_bib31","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1021\/acs.accounts.8b00439","article-title":"Systems approaches for unveiling the mechanism of action of bismuth drugs: new medicinal applications beyond Helicobacter pylori infection","volume":"52","author":"Li","year":"2019","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.cbpa.2022.102127_bib32","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41586-018-0327-4","article-title":"Challenges and recent progress in drug discovery for tropical diseases","volume":"559","author":"De Rycker","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.cbpa.2022.102127_bib33","series-title":"Chagas disease (American trypanosomiasis)","year":"2021"},{"key":"10.1016\/j.cbpa.2022.102127_bib34","series-title":"Neglected tropical diseases","year":"2021"},{"key":"10.1016\/j.cbpa.2022.102127_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26154629","article-title":"An overview on target-based drug design against kinetoplastid Protozoan infections: human African trypanosomiasis, Chagas disease and leishmaniases","volume":"26","author":"Kourbeli","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.cbpa.2022.102127_bib36","doi-asserted-by":"crossref","first-page":"105906","DOI":"10.1016\/j.ijantimicag.2020.105906","article-title":"Searching for drugs for Chagas disease, leishmaniasis and schistosomiasis: a review","volume":"55","author":"Santos","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cbpa.2022.102127_bib37","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1021\/acs.chemrev.8b00338","article-title":"Metal compounds against neglected tropical diseases","volume":"119","author":"Ong","year":"2019","journal-title":"Chem Rev"},{"key":"10.1016\/j.cbpa.2022.102127_sref38","first-page":"331","article-title":"Metal compounds in the development of antiparasitic agents: rational design from basic chemistry to the clinic","volume":"19","author":"Gambino","year":"2019","journal-title":"Met Ions Life Sci"},{"key":"10.1016\/j.cbpa.2022.102127_bib39","series-title":"Comparative genomics of trypanosomatid parasitic Protozoa","first-page":"404","volume":"309","author":"El-Sayed","year":"2005"},{"key":"10.1016\/j.cbpa.2022.102127_bib40","doi-asserted-by":"crossref","first-page":"D457","DOI":"10.1093\/nar\/gkp851","article-title":"TriTrypDB: a functional genomic resource for the Trypanosomatidae","volume":"38","author":"Aslett","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cbpa.2022.102127_bib41","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1172\/JCI33945","article-title":"Kinetoplastids: related protozoan pathogens, different diseases","volume":"118","author":"Stuart","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cbpa.2022.102127_bib42","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.1110289","article-title":"The trypanosoma cruzi proteome","volume":"309","author":"Atwood","year":"2005","journal-title":"Sience"},{"key":"10.1016\/j.cbpa.2022.102127_bib43","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jprot.2014.12.003","article-title":"Reevaluating the Trypanosoma cruzi proteomic map: the shotgun description of bloodstream trypomastigotes","volume":"115","author":"Brunoro","year":"2015","journal-title":"J\u00a0Proteonomics"},{"key":"10.1016\/j.cbpa.2022.102127_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188441","article-title":"Transcriptome-wide analysis of the Trypanosoma cruzi proliferative cycle identifies the periodically expressed mRNAs and their multiple levels of control","volume":"12","author":"Chavez","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cbpa.2022.102127_bib45","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1002\/jcb.25978","article-title":"Transcriptome and functional genomics reveal the participation of adenine phosphoribosyltransferase in Trypanosoma cruzi resistance to benznidazole","volume":"118","author":"Garcia-Huertas","year":"2017","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.cbpa.2022.102127_sref46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/microorganisms8060950","article-title":"Experimental strategies to explore drug action and resistance in kinetoplastid parasites","volume":"8","author":"Van den Kerkhof","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.cbpa.2022.102127_bib47","series-title":"American trypanosomiasis Chagas disease","first-page":"371","article-title":"Biochemistry of Trypanosoma cruzi","author":"Docampo","year":"2017"},{"key":"10.1016\/j.cbpa.2022.102127_bib48","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s10534-018-0140-4","article-title":"Effect of a new anti-T.\u00a0cruzi metallic compound based on palladium","volume":"31","author":"Mosquillo","year":"2018","journal-title":"Biometals"},{"key":"10.1016\/j.cbpa.2022.102127_bib49","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1111\/cbdd.13332","article-title":"Trypanosoma cruzi biochemical changes and cell death induced by an organometallic platinum-based compound","volume":"92","author":"Mosquillo","year":"2018","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.cbpa.2022.102127_sref50","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1039\/d0mt00030b","article-title":"Comparative high-throughput analysis of the Trypanosoma cruzi response to organometallic compounds","volume":"12","author":"Mosquillo","year":"2020","journal-title":"Metallomics"},{"key":"10.1016\/j.cbpa.2022.102127_sref51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/1634270","article-title":"High throughput approaches to unravel the mechanism of action of a new vanadium-based compound against Trypanosoma cruzi","author":"Mosquillo","year":"2020","journal-title":"Bioinorgan Chem Appl"},{"key":"10.1016\/j.cbpa.2022.102127_bib52","doi-asserted-by":"crossref","first-page":"11900","DOI":"10.1039\/c3dt50512j","article-title":"A\u00a0new series of heteroleptic oxidovanadium (IV) compounds with phenanthroline-derived co-ligands: selective Trypanosoma cruzi growth inhibitors","volume":"42","author":"Fern\u00e1ndez","year":"2013","journal-title":"Dalton Trans"},{"key":"10.1016\/j.cbpa.2022.102127_bib53","doi-asserted-by":"crossref","first-page":"14453","DOI":"10.1039\/C5DT00557D","article-title":"Gambino D: Aromatic amine N-oxide organometallic compounds: searching for prospective agents against infectious diseases","volume":"44","author":"Rodr\u00edguez Arce","year":"2015","journal-title":"Dalton Trans"}],"container-title":["Current Opinion in Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367593122000126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367593122000126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T02:48:02Z","timestamp":1761274082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367593122000126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":53,"alternative-id":["S1367593122000126"],"URL":"https:\/\/doi.org\/10.1016\/j.cbpa.2022.102127","relation":{},"ISSN":["1367-5931"],"issn-type":[{"value":"1367-5931","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metallomics and other omics approaches in antiparasitic metal-based drug research","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbpa.2022.102127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102127"}}